ATE187329T1 - Carnitinderivat als arzneimittel zur behandlung von arteriosklerose obliterans - Google Patents
Carnitinderivat als arzneimittel zur behandlung von arteriosklerose obliteransInfo
- Publication number
- ATE187329T1 ATE187329T1 AT96830093T AT96830093T ATE187329T1 AT E187329 T1 ATE187329 T1 AT E187329T1 AT 96830093 T AT96830093 T AT 96830093T AT 96830093 T AT96830093 T AT 96830093T AT E187329 T1 ATE187329 T1 AT E187329T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- arteriosclerosis obliterans
- medicinal product
- carnitine derivative
- carnitine
- Prior art date
Links
- 208000000575 Arteriosclerosis Obliterans Diseases 0.000 title abstract 2
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 title abstract 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical class C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 206010022562 Intermittent claudication Diseases 0.000 abstract 1
- UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000021156 intermittent vascular claudication Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96830093A EP0793962B1 (de) | 1996-03-04 | 1996-03-04 | Carnitinderivat als Arzneimittel zur Behandlung von Arteriosklerose obliterans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE187329T1 true ATE187329T1 (de) | 1999-12-15 |
Family
ID=8225823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96830093T ATE187329T1 (de) | 1996-03-04 | 1996-03-04 | Carnitinderivat als arzneimittel zur behandlung von arteriosklerose obliterans |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5811457A (de) |
| EP (1) | EP0793962B1 (de) |
| JP (1) | JPH09323927A (de) |
| KR (1) | KR100346883B1 (de) |
| AT (1) | ATE187329T1 (de) |
| CA (1) | CA2198833C (de) |
| DE (1) | DE69605531T2 (de) |
| DK (1) | DK0793962T3 (de) |
| ES (1) | ES2141463T3 (de) |
| GR (1) | GR3032903T3 (de) |
| PT (1) | PT793962E (de) |
| TW (1) | TW349863B (de) |
| ZA (1) | ZA971808B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1276253B1 (it) | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
| IT1295408B1 (it) * | 1997-10-03 | 1999-05-12 | Sigma Tau Ind Farmaceuti | Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo |
| AU1294600A (en) * | 1998-11-11 | 2000-05-29 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis |
| AU1258699A (en) * | 1998-11-11 | 2000-05-29 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of propionylcarnitine for the manufacture of a medicament for inhibiting smooth muscle cell proliferation |
| IT1316998B1 (it) * | 2000-03-02 | 2003-05-26 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori. |
| ITRM20010708A1 (it) | 2001-12-04 | 2003-06-04 | Sigma Tau Ind Farmaceuti | Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile. |
| JPWO2003087080A1 (ja) * | 2002-04-18 | 2005-08-18 | 中外製薬株式会社 | 血管内皮の血管張力調節機能を改善するための医薬組成物 |
| US7776913B2 (en) * | 2002-12-13 | 2010-08-17 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Carnitines for treating or preventing disorders caused by andropause |
| US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
| WO2006061341A1 (en) * | 2004-12-10 | 2006-06-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of propionyl l-carnitine for the preparation of a high-dose medicament for the treatment of peripheral arterial disease |
| US7560485B2 (en) * | 2005-10-04 | 2009-07-14 | Sigma-Tau Industrie Parmaceutiche Riunite S.P.A. | Method for treating intermittent claudication comprising the administration of propionyl L-carnitine and a concomitant physical training |
| EP2353596A1 (de) | 2010-02-02 | 2011-08-10 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Kombinationszusammensetzung mit L-Carnitin oder Proponyl-L-Carnitin als Wirkstoffe zur Vorbeugung oder Behandlung von chronischer Veneninsuffizienz |
| PT2582368T (pt) | 2010-06-16 | 2018-06-04 | Alfasigma Spa | Acetil-carnitina, para utilização num método para o aumento da neurogénese em tecido neuronal |
| EP2642991A1 (de) | 2010-11-22 | 2013-10-02 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutisches verfahren zur behandlung der leberschen optikusatrophie |
| KR20130140100A (ko) | 2010-12-09 | 2013-12-23 | 씨그마-토 인더스트리에 파마슈티체 리유니테 에스. 피. 에이. | 피부 장애 치료용 국소 사용을 위한 조성물 |
| EP2783695A1 (de) | 2013-03-28 | 2014-10-01 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Physiologische Ergänzung oder Medikament zur ophthalmischen Verwendung mit L-Carnitin oder Alkanoyl-L-Carnitinen in Kombination mit Eledoisin |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1206954B (it) * | 1979-02-12 | 1989-05-17 | Sigma Tau Ind Farmaceuti | Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche |
| IT1142934B (it) * | 1981-11-06 | 1986-10-15 | Sigma Tau Ind Farmaceuti | Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene |
| US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
-
1996
- 1996-03-04 AT AT96830093T patent/ATE187329T1/de active
- 1996-03-04 ES ES96830093T patent/ES2141463T3/es not_active Expired - Lifetime
- 1996-03-04 PT PT96830093T patent/PT793962E/pt unknown
- 1996-03-04 DK DK96830093T patent/DK0793962T3/da active
- 1996-03-04 DE DE69605531T patent/DE69605531T2/de not_active Expired - Lifetime
- 1996-03-04 EP EP96830093A patent/EP0793962B1/de not_active Expired - Lifetime
- 1996-09-16 US US08/714,424 patent/US5811457A/en not_active Expired - Lifetime
-
1997
- 1997-01-28 TW TW086100923A patent/TW349863B/zh not_active IP Right Cessation
- 1997-02-12 KR KR1019970004057A patent/KR100346883B1/ko not_active Expired - Fee Related
- 1997-02-28 CA CA002198833A patent/CA2198833C/en not_active Expired - Fee Related
- 1997-03-03 ZA ZA971808A patent/ZA971808B/xx unknown
- 1997-03-04 JP JP9048765A patent/JPH09323927A/ja active Pending
-
2000
- 2000-03-08 GR GR20000400598T patent/GR3032903T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0793962A1 (de) | 1997-09-10 |
| MX9701294A (es) | 1997-09-30 |
| CA2198833A1 (en) | 1997-09-04 |
| CA2198833C (en) | 2003-07-22 |
| JPH09323927A (ja) | 1997-12-16 |
| PT793962E (pt) | 2000-05-31 |
| US5811457A (en) | 1998-09-22 |
| DE69605531D1 (de) | 2000-01-13 |
| TW349863B (en) | 1999-01-11 |
| DK0793962T3 (da) | 2000-05-22 |
| GR3032903T3 (en) | 2000-07-31 |
| ZA971808B (en) | 1998-07-31 |
| ES2141463T3 (es) | 2000-03-16 |
| EP0793962B1 (de) | 1999-12-08 |
| KR970064602A (ko) | 1997-10-13 |
| DE69605531T2 (de) | 2000-05-31 |
| KR100346883B1 (ko) | 2003-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69605531D1 (de) | Carnitinderivat als Arzneimittel zur Behandlung von Arteriosklerose obliterans | |
| DE69831016D1 (de) | System zur überwachung und behandlung von schlafstörungen mittels eines transtrachealen katheters | |
| DE69331605D1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| ATE204704T1 (de) | Verwendung von bcl-2 zur herstellung von arzneimitteln zur therapeutischen behandlung und verhinderung von krankheiten | |
| DE69204639D1 (de) | Verwendung von Modafinil zur Herstellung eines antiischämischen Arzneimittels. | |
| ATE224714T1 (de) | Behandlung von tinnitus mit neuroprotektiven wirkstoffen | |
| ATE141505T1 (de) | Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht | |
| ATE212837T1 (de) | Pharmazeutische zubereitung zur behandlung akuter rhinitiden, enthaltend sympthomimeticum und pantothenol und/oder pantothensäure | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| NO975234L (no) | Fremgangsmåte for behandling av maniske og bipolare forstyrrelser | |
| DE68911891D1 (de) | Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung. | |
| NO944339D0 (no) | Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser | |
| ATE183088T1 (de) | Arzneimittel zur behandlung von hauterkrankungen | |
| TR199902335T2 (xx) | Vask�ler bozukluklar�n tedavisi. | |
| DK0836853T3 (da) | Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom | |
| NO953072D0 (no) | Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom | |
| ATE198831T1 (de) | Verwendung von triazinverbindungen zur herstellkung eines arzneimittels zur behandlung von erinnerungs-und lernstörungen | |
| DE69800906D1 (de) | Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie | |
| DE69228235D1 (de) | Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung | |
| ATE301998T1 (de) | Verwendung von isovaleryl-l-carnitin zur herstellung eines arzneimittels zur vorbeugung und therapie von osteoporose | |
| ATE213945T1 (de) | Verwendung von olanzapin zur herstellung eines arzneimittels zur neuroprotektion | |
| DE69215191D1 (de) | Verwendung von thiol-5-(2-diethyl-aminoethyl)-ester-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der neuromuskuläre Inkontinenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |